CHICAGO – Navigating the patent landscape in developing countries is hard enough, and made even trickier by such moves as the one made earlier this month by El Salvador, which passed a law that cut prices by at least 30 percent for more than 6,000 medicines, and as much as 60 percent for the most common therapies.